A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with90Y glass microspheres

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 56, Issue 6, 2012, Pages 503-508

  Chiesa, C ^a   Mira, M ^b   Maccauro, M ^a   Romito, R ^a   Spreafico, C ^a   Sposito, C ^a   Bhoori, S ^a   Morosi, C ^a   Pellizzari, S ^c   Negri, A ^b   Civelli, E ^a   Lanocita, R ^a   Camerini, T ^a   Bampo, C ^a   Carrara, M ^a   Seregni, E ^a   Marchiano A ^a   Mazzaferro, V ^a   Bombardieri, E ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Clinical protocols; Embolization, therapeutic; Radiometry

Indexed keywords

GLASS; MICROSPHERE; RESIN; YTTRIUM 90;

AREA UNDER THE CURVE; ARTIFICIAL EMBOLISM; CANCER INCIDENCE; CANCER PATIENT; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DOSIMETRY; HUMAN; HYPOTHESIS; LIVER CELL CARCINOMA; LIVER PARENCHYMA; LIVER TOXICITY; MAJOR CLINICAL STUDY; PROBABILITY; RANK SUM TEST; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SAFETY; TREATMENT PLANNING;

AGED; BRACHYTHERAPY; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; RADIOMETRY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 84875356502     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Ahmadzadehfar H, Biersack HJ, Ezziddin S. Radioembolization of Liver Tumors With Yttrium-90 Microspheres. Semin Nucl Med 2010;40:105-21.
2. Giammarile F, Bodei L, Chiesa C, Flux G, Forrer F, Kraeber-Bodere F. EANM procedure guidelines for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging 2011;38:1393-406.
3. TheraSphere® Yttrium-90 Glass Microspheres. Instructions for Use [Internet]. Available at http://www.mdsnordion.com/therasphere/physicians- package-insert/package-insert-eu-en.pdf [cited 2012, Nov 5].
4. 90Y microspheres. Q J Nucl Med Mol Im 2011;55:168-97.
5. Mazzaferro V, Sposito C, Bhoori S, Romito R, Chiesa C, Morosi C et al. Yttrium-90 radioembolization for intermediate-advanced hepatocarcinoma: a phase II study. Hepatology 2012 [Epub ahead of print].
6. Ho S, Lau WY, Leung TWT, Chan M, Ngar YK, Johnson PJ. Partition model for estimating radiation doses from yttrium-90 micropheres in treating hepatic tumours. Eur J Nucl Med 1996;23:947-52. (Pubitemid 26278795)
7. Ho S, Lau WY, Leung TWT, Chan M, Johnson PJ, Li AKC. Clinical evaluation of the partition model for estimate radiation doses from yttrium-90 mirospheres in the treatment of hepatic cancer. Eur J Nucl Med 1997;24:293-8. (Pubitemid 27165858)
8. Flamen P, Vanderlinde B, Delatte P, Ghanem G, Ameye L, Van Den Eynde M et al. Multimodality imaging can predict the metabolic response of unresectable colorectel liver metastases to radioembolization therapy with yttrium-90 labeled resin micropheres. Phys Med Biol 2008;53:6591-603.
9. Strigari L, Sciuto R, Rea S, Carpanese L, Pizzi G, Soriani A et al. Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y SIR spheres: radiobiological considerations. J Nucl Med 2010;51:1377-85.
10. 90Y-Loaded glass microspheres: preliminary results J Nucl Med 2012;53:255-63.
11. Cremonesi M, Ferrari M, Bartolomei M, Orsi F, Bonomo G, Aricò D et al. Radioembolization with 90Y-microspheres: dosimetric and radiobiological investigation for multi-cycle treatment. Eur J Nucl Med Mol Imaging 2008;35:2088-96.
12. Sangro B, Gil-Alzugaray B, Rodriguez J, Sola I, Martinez-Questa A, Viudez A et al. Liver disease induced by radioembolization of liver tumours. Cancer 2008;112:1539-46.
13. 90Y radioembolization. J Nucl Med 2012;53:559-66.
14. Dewaraja YK, Frey EC, Sgouros G, Brill AB, Roberson P, Zanzonico PB et al. MIRD pamphlet No. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy. J Nucl med 2012;53:1-16.
15. Bolch WE, Bouchet LG, Robertson JS, Wessels BW, Siegel JA, Howell RW et al. MIRD pamphlet No. 17: the dosimetry of non-uniform activity distributions - radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee. J Nucl Med 1999;40:11S-36S. (Pubitemid 29044199)
16. Agresti A, Coulll BA. Approximate is better than "exact" for internal estimation of binomial proportions. The American Statistician 1998:52.